Abstract
Nanomedicine is a multidisciplinary research field with an integration of traditional sciences such as chemistry, physics, biology and materials science. The application of nanomedicine for lung diseases as a relatively new area of interdisciplinary science has grown rapidly over the last 10 years. Promising research outcomes suggest that nanomedicine will revolutionise the practice of medicine, through the development of new approaches in therapeutic agent delivery, vaccine development and nanotechnology-based medical detections. Nano-based approaches in the diagnosis and treatment of lung diseases will, in the not too distant future, change the way we practise medicine. This review will focus on the current trends and developments in the clinical translation of nanomedicine for lung diseases, such as in the areas of lung cancer, cystic fibrosis, asthma, bacterial infections and COPD.
Funder
Science Foundation Ireland
Subject
Pulmonary and Respiratory Medicine
Reference129 articles.
1. The top 10 causes of death: World Health Organisation, 2018. Available: http://www.who.int/en/news-room/fact-sheets/detail/the-top-10-causes-of-death [Accessed 2018].
2. The burden of lung disease: the European Lung white book, 2011. Available: https://www.erswhitebook.org/chapters/the-burden-of-lung-disease/ [Accessed 2018].
3. Nanotechnology in respiratory medicine
4. Medical nanoparticles for next generation drug delivery to the lungs
5. Synthetic Nanoparticles for Vaccines and Immunotherapy
Cited by
59 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献